Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Pulmonary Circulation
Volume 7, Issue 1, Pages 145-155
Publisher
SAGE Publications
Online
2016-10-28
DOI
10.1086/690017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gaining insights into pulmonary hypertension in respiratory diseases
- (2015) Joan Albert Barberà et al. EUROPEAN RESPIRATORY JOURNAL
- Severe pulmonary hypertension in lung disease: phenotypes and response to treatment
- (2015) Melanie J. Brewis et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction
- (2015) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
- (2015) Nazzareno Galiè et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
- (2015) Kurt W. Prins et al. JACC-Heart Failure
- Use of Pulmonary Arterial Hypertension–Approved Therapy in the Treatment of Non–Group 1 Pulmonary Hypertension at US Referral Centers
- (2015) Aaron W. Trammell et al. Pulmonary Circulation
- Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
- (2015) Marius M. Hoeper et al. PLoS One
- Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
- (2014) Tamera J. Corte et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis
- (2014) Rajeev Saggar et al. THORAX
- Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
- (2014) Andrew R Goudie et al. Lancet Respiratory Medicine
- Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan
- (2013) Ganesh Raghu ANNALS OF INTERNAL MEDICINE
- Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction
- (2013) MeiLan K. Han et al. CHEST
- Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial
- (2013) Isabel Blanco et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary Hypertension in Chronic Lung Diseases
- (2013) Werner Seeger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial
- (2012) David J. Lederer et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
- (2012) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease
- (2012) Kasper Hasseriis Andersen et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis
- (2012) Motohiro Kimura et al. RESPIRATION
- Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
- (2012) Omar A. Minai et al. RESPIRATORY MEDICINE
- Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis and 6 min walk test
- (2012) Charlotte U. Andersen et al. RESPIRATORY MEDICINE
- The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease
- (2010) Tamera J. CORTE et al. RESPIROLOGY
- Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension
- (2009) Micah R. Fisher et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease
- (2009) Giuseppe Valerio et al. Therapeutic Advances in Respiratory Disease
- Pulmonary hypertension in interstitial lung disease
- (2008) J. Behr et al. EUROPEAN RESPIRATORY JOURNAL
- A randomised, controlled trial of bosentan in severe COPD
- (2008) D. Stolz et al. EUROPEAN RESPIRATORY JOURNAL
- Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
- (2008) Steven D. Nathan et al. RESPIRATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started